Lawrence, KS, United States of America

Euna Yoo


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Euna Yoo: Innovator in Therapeutic Compounds

Introduction

Euna Yoo is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of therapeutic compounds, particularly through her innovative work on Toll-like receptor agonists. Her research focuses on developing compounds that can be utilized for various therapeutic purposes.

Latest Patents

Euna Yoo holds 1 patent related to Toll-like receptor agonists. The patent describes compounds that can be used therapeutically, specifically as TLR agonists, such as TLR7 or TLR8 agonists. These compounds can be included in pharmaceutical compositions and are useful in therapies where TLR agonism is beneficial. The patent outlines that the compounds may include various ingredients common in pharmaceutical formulations, such as carriers, diluents, excipients, and fillers. Additionally, the compounds can serve as adjuvants in vaccines and have various forms, including derivatives, prodrugs, salts, stereoisomers, tautomers, and polymorphs.

Career Highlights

Euna Yoo is affiliated with the University of Kansas Medical Center Research Institute, where she conducts her research. Her work has garnered attention for its potential applications in therapeutic settings, particularly in vaccine development and other medical therapies.

Collaborations

Euna collaborates with notable colleagues, including Sunil Abraham David and Nikunj Shukla. Their combined expertise contributes to the advancement of research in therapeutic compounds.

Conclusion

Euna Yoo's innovative work in the field of Toll-like receptor agonists highlights her significant contributions to therapeutic research. Her patent and collaborations reflect her commitment to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…